Medical Director

Role: Medical Director supporting clinical development of Revolution Medicines' targeted RAS inhibitors in oncology, focusing on data integrity and regulatory submissions. Responsibilities: oversee clinical data review, ensure compliance with GxP standards, lead cross-functional teams in data cleaning and regulatory documentation, and contribute to strategic clinical development plans. Collaborate with Regulatory Affairs, Data Management, and Medical Writing to support NDA/BLA/MAA processes; prepare dossiers and responses for health authorities; and mentor clinical teams. Requirements: MD (or equivalent), board-certified in Oncology, with 5+ years in clinical development, preferably in solid tumors or GI malignancies; experience with NDA/BLA data review and regulatory submissions; strong knowledge of GCP, ICH, FDA, EMA guidelines; excellent communication skills. Preferred: experience with regulatory interactions (e.g., NDA, BLA, Breakthrough Therapy Designation), leading major submissions, and engaging with health authorities and KOLs. High-Value: Oncology, RAS pathway, targeted therapies, clinical-stage molecules, regulatory dossier preparation, cross-functional leadership, and global regulatory coordination. Work setup: onsite in Redwood City, CA, with a salary range of $295K-$339K USD.